Skip to main content
. 2020 May 15;34(9):1957–1971. doi: 10.1111/jdv.16339

Figure 3.

Figure 3

Risk variants identified in various genes involved in EN pathogenesis. Genetic associations have been shown in genes involved in drug metabolism influencing the levels of the drug or its metabolite involved (CYP2B6, CYP2C9, GSTM1); in cellular uptake and peptide presentation by antigen‐presenting cells (ABC transporters, proteasome); in the HLA‐TCR interaction (HLA I, TCR repertoire); in factors influencing CD8 + T‐cell function (CTLA4); in other immune cells shaping the subsequent immune response (HLA II, IL4R, IL13, EP3, TLR3, IKZF1, TRAF3IP2, FasL).